Nolato AB
OTC:NLTBF

Watchlist Manager
Nolato AB Logo
Nolato AB
OTC:NLTBF
Watchlist
Price: 6.53 USD Market Closed
Market Cap: $1.8B

Nolato AB
Investor Relations

Nolato AB's journey began in the early 20th century, establishing itself at the heart of Sweden's burgeoning manufacturing industry. Originally a small operator, Nolato has evolved into a multinational leader in polymer-based product solutions, spanning a myriad of sectors including medical technology, telecommunications, and industrial applications. At its core, Nolato thrives on integrating sustainable practices with precision engineering, leveraging cutting-edge technology to meet the demands of its diversified clientele. By emphasizing collaborative innovation, the company consistently delivers customized solutions, helping its partners overcome manufacturing and product design challenges.

The engine behind Nolato's robust business model is its ability to adapt and innovate in sync with industry needs. Its operations revolve around three primary business areas: Medical Solutions, Integrated Solutions, and Industrial Solutions. Through Medical Solutions, Nolato produces highly specialized polymer components for medical and pharmaceutical devices, catering to a market that demands flawless precision and stringent regulatory compliance. Integrated Solutions focuses on developing advanced electronics for consumer products, notably in sectors like smartphones and consumer electronics, where Nolato's expertise in electromagnetic shielding is a vital asset. Meanwhile, Industrial Solutions provides comprehensive manufacturing and assembly services for sectors ranging from automotive to other industrial applications. By harnessing its technological prowess and focusing on sustainable, value-based growth, Nolato continuously strengthens its position as a dynamic player in the global manufacturing landscape.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2024
Call Date
Oct 25, 2024
AI Summary
Q3 2024

Solid Growth: Nolato reported sales growth of approximately 5% in Q3 2024, with increases seen in both business areas.

Margin Expansion: EBITDA rose 22% to SEK 235 million, resulting in a margin of 9.8%, up from last year, thanks to cost controls and efficiency improvements.

Medical Solutions Recovery: Growth returned in In Vitro Diagnostics after a post-COVID slowdown, but some areas like Pharmaceutical Packaging faced lower volumes due to inventory adjustments.

Engineered Solutions Dynamics: Engineered Solutions saw 4% growth (currency adjusted), with Materials up 17%, while Automotive volumes declined and are expected to remain weak into Q4.

Cash Flow Strength: Cash flow from operations improved to SEK 327 million, supporting ongoing investments.

CapEx Guidance: Full-year 2024 capital expenditures are expected at about SEK 700 million, with ongoing investment tied to a major medical project.

Outlook Mixed: Management expects continued softness in Automotive and ongoing supply chain adjustments in some Medical segments, but sees potential for further telecom/materials recovery.

Key Financials
Net Sales
SEK 2.4 billion
Operating Profit
SEK 235 million
EBITDA Margin
9.8%
Cash Flow from Operating Activities
SEK 327 million
Net Investments
SEK 136 million
Adjusted Earnings per Share
SEK 0.61
Return on Capital Employed
11.5%
Medical Solutions Sales
SEK 1,355 million
Medical Solutions Operating Profit
SEK 145 million
Medical Solutions Margin
10.7%
Materials Sales Growth
Up 17% (currency adjusted)
Capital Expenditure (CapEx)
SEK 700 million (expected full year 2024)
Other Earnings Calls

Management

Mr. Christer Wahlquist MBA, ME
President, CEO & Interim President of Industrial Solutions
No Bio Available
Mr. Per-Ola Holmstrom MBA
Deputy CEO & CFO
No Bio Available
Mr. Glenn Svedberg
Group Sustainability Director & Technology Director
No Bio Available
Mr. Mats Håkansson
Group Corporate Communication Manager
No Bio Available
Mr. Dan Wong
Managing Director of Nolato Lovepac Converting
No Bio Available
Mr. Johan Iveberg
President of Medical Solutions
No Bio Available
Thomas Hofflander
Managing Director of Nolato Beijing Medical & Nolato Beijing
No Bio Available
Olof Pettersson
Managing Director of Nolato Gota & Nolato Plastteknik
No Bio Available
Henrik Enoksson
Managing Director of Nolato Lövepac
No Bio Available
Anders Willman
Managing Director of Nolato Polymer
No Bio Available

Contacts

Address
SKANE
Nolatovagen 32, Torekov
Contacts
+46431442290.0
www.nolato.com